WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped down before the market opened on Wednesday. The stock had previously closed at $13.55, but opened at $12.48. WuXi Biologics (Cayman) shares last traded at $12.53, with a volume of 2,894 shares changing hands.
Analyst Ratings Changes
Separately, Zacks Research raised shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat, the company currently has an average rating of “Hold”.
Get Our Latest Research Report on WXXWY
WuXi Biologics (Cayman) Stock Up 1.2%
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.
Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.
Recommended Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
